KPIs & Operating Metrics(New)

Balance Sheet

Cash Flow Statement

Acquisitions Amortization of Goodwill Amortization of Goodwill Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Discontinued Operations Cash from Discontinued Operations Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Accured Expenses Change in Accured Expenses Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Change in Taxes Change in Taxes Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Divestments Dividends Paid - Common Dividends Paid - Common Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased Short-Term Debt issuances

Daily Values

Growth Metrics

Clorox (CLX) Long-Term Debt Issuances (2017 - 2018)

Clorox has reported Long-Term Debt Issuances over the past 5 years, most recently at $495.0 million for Q2 2018.

Quarterly results put Long-Term Debt Issuances at $495.0 million for Q2 2018, changed N/A from a year ago — trailing twelve months through Mar 2019 was $495.0 million (up 25.0% YoY), and the annual figure for FY2022 was $1.1 billion, changed.
Long-Term Debt Issuances for Q2 2018 was $495.0 million at Clorox, up from $396.0 million in the prior quarter.
Over the last five years, Long-Term Debt Issuances for CLX hit a ceiling of $495.0 million in Q2 2018 and a floor of $396.0 million in Q3 2017.